AMPH
Amphastar Pharmaceuticals
Stock NASDAQ – Stock Market Prices, News & Analysis
Amphastar Pharmaceuticals is a biopharmaceutical company that develops and commercializes injectable and inhalable therapeutic products.
Amphastar Pharmaceuticals
AMPH
Amphastar Pharmaceuticals is a biopharmaceutical company that develops and commercializes injectable and inhalable therapeutic products.
Price history of Amphastar Pharmaceuticals
Price history of Amphastar Pharmaceuticals
Performance & Momentum
Strategic Analysis
Amphastar Pharmaceuticals • 2026
Amphastar Pharmaceuticals positions itself in the injectable and inhalable pharmaceutical product segment, combining innovation and specialization in complex dosage forms. Its niche relies on therapeutic solutions targeting specialty markets where the technical entry barrier is high.
Strengths
- Well-recognized expertise in the development of injectable and inhalable forms
- Portfolio focused on high therapeutic added-value products
- Strong performance history over the medium to long term
Weaknesses
- Marked volatility due to competitive and regulatory pressure
- Dependence on regulatory approval cycles that may impact visibility
Momentum
The current momentum shows signs of stabilization after a withdrawal phase over the past year, supported by a notable medium-term rebound. This development suggests a potential consolidation of the stock price, which could offer an attractive entry point if the company confirms its ability to renew its pipeline.
Similar stocks to Amphastar Pharmaceuticals
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
